{"analyses":[{"ciNumSides":"TWO_SIDED","groupDescription":"Estrogen receptor (ER) status correlation with progression-free survival for patients on study treatment.","groupIds":["OG000"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","paramType":"Hazard Ratio (HR)","paramValue":"-0.708","statisticalMethod":"Cox Proportional Hazards","testedNonInferiority":false}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24"}]}],"title":"Positive Status"},{"categories":[{"measurements":[{"groupId":"OG000","value":"14"}]}],"title":"Negative Status"}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"}],"units":"Participants"}],"groups":[{"id":"OG000","title":"Women Treated With Adjuvant Regimen for High Risk Uterine LMS"}],"paramType":"NUMBER","populationDescription":"Only 38 of the 47 patients were evaluable","reportingStatus":"POSTED","timeFrame":"2 years","title":"Correlation Between Estrogen Receptor (ER) Status and Tumor Response to Treatment (PFS)","type":"SECONDARY","unitOfMeasure":"participants"}